Meridian Bioscience Inc. (VIVO) reported third quarter EPS of $0.19 Thursday morning, which matched the consensus estimate. The company also reaffirmed its full year EPS forecast of $0.72 to $0.75.
Meridian Bioscience gapped down sharply Thursday and declined throughout the final 2 hours of trade. The stock finished down by $4.74 at $24.00 on strong volume. The stock dropped below support to close at an 11-month low.
For comments and feedback: editorial@rttnews.com